The MEK inhibitor trametinib for the treatment of advanced melanoma
Year: 2014
Type: article
Source: Expert Opinion on Orphan Drugs
Institution: Vanderbilt University Medical Center
Language: English
Topic: Melanoma and MAPK Pathways
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2125845533